摘要
动脉粥样硬化是急性心血管疾病的主要病理生理过程。危险的生命状况,如心肌梗死和缺血性中风,是由脆弱的动脉粥样硬化斑块的突然破裂,其特点是薄、高度发炎和胶原纤维。而先天和适应性炎症逐渐成为这个过程的驱动力,更是对中性粒细胞(PMN)的参与。在过去的二十年里,中性粒细胞在不同的酶的释放促进斑块易损性中起到重要的作用,实验技术的进步,如明胶酶(基质金属蛋白酶)和胶原酶,弹性蛋白酶髓过氧化物酶的使用。因此,中性粒细胞及其产物的循环水平的研究已在一级和二级预防斑块的不稳定性对心血管疾病的潜在标志物。此外,不同类别的针对中性粒细胞活化药物的开发正在成为一个有趣的研究领域。本综述将提供对中性粒细胞在促进斑块的易损性也讨论治疗策略针对中性粒细胞在斑块易损性的潜在影响的更新。
关键词: 动脉粥样硬化,炎症,基质金属蛋白酶,髓过氧化物酶,中性粒细胞,易损斑块。
图形摘要
Current Drug Targets
Title:Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
Volume: 16 Issue: 4
Author(s): Federico Carbone, Francois Mach and Fabrizio Montecucco
Affiliation:
关键词: 动脉粥样硬化,炎症,基质金属蛋白酶,髓过氧化物酶,中性粒细胞,易损斑块。
摘要: Atherosclerosis is the main pathophysiological process underlying acute cardiovascular diseases. Life-threatening conditions, such as myocardial infarction and ischemic stroke, are provoked by the sudden rupture of vulnerable atherosclerotic plaques, characterized by thin, highly inflamed and collagen-poor fibrous cap. Whereas both innate and adaptive inflammation progressively emerged as driving force of this processes, less is known about the involvement of neutrophils (PMNs). Advances in laboratory techniques during the last two decades disclosed that PMNs play a crucial role in promoting plaque vulnerability by the release of different enzymes, such as gelatinases (matrix metalloproteinases) collagenases, elastase and myeloperoxidase. Accordingly, circulating levels of PMNs and their products have been investigated as potential markers of plaque instability in both primary and secondary prevention on cardiovascular diseases. In addition, the development of different classes of drugs targeting PMNs activation is emerging as an interesting field of research. This narrative review will provide an update on the role of PMNs in promoting plaque vulnerability also discussing the potential effects of therapeutic strategies targeting PMN on plaque vulnerability.
Export Options
About this article
Cite this article as:
Federico Carbone, Francois Mach and Fabrizio Montecucco , Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability, Current Drug Targets 2015; 16 (4) . https://dx.doi.org/10.2174/1389450115666141110093013
DOI https://dx.doi.org/10.2174/1389450115666141110093013 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The GH/IGF-1 Axis in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Mechanisms of Thrombosis, Available Treatments and Management Challenges Presented by Thromboangiitis Obliterans
Current Medicinal Chemistry Foreword
Current Nutrition & Food Science Editorial (Novel Therapies and Botanical and Mechanical Approaches for Management of Cardiovascular Disease)
Recent Patents on Cardiovascular Drug Discovery Psychological Stress in Pathogenesis of Essential Hypertension
Current Hypertension Reviews Drug Delivery to CNS: Challenges and Opportunities with Emphasis on Biomaterials Based Drug Delivery Strategies
Current Pharmaceutical Design Abeta Immunotherapy and Other Means to Remove Amyloid
Current Drug Targets - CNS & Neurological Disorders Desmoteplase for Acute Ischemic Stroke: A Systematic Review and Metaanalysis of Randomized Controlled Trials
CNS & Neurological Disorders - Drug Targets Features for Heartbeat Sound Signal Normal and Pathological
Recent Patents on Computer Science Resveratrol and Cardiovascular Disease
Current Nutrition & Food Science Reduction of Myocardial Ischemia-Reperfusion Injury with Pre- and Postconditioning: Molecular Mechanisms and Therapeutic Targets
Cardiovascular & Hematological Disorders-Drug Targets Activation of the Innate Immune System in Atherosclerotic Disease
Current Pharmaceutical Design Dysglycemia and Abdominal Obesity
Current Vascular Pharmacology Neuroprotective Therapies for Alzheimers Disease
Current Pharmaceutical Design The Role of Endogenous H2S in Cardiovascular Physiology
Current Pharmaceutical Biotechnology Obesity and Pregnancy
Current Women`s Health Reviews Safety Analysis and Improved Cardiac Function Following Local Autologous Transplantation of CD133+ Enriched Bone Marrow Cells After Myocardial Infarction
Current Neurovascular Research Maternal Nutrition and Predisposition to Later Kidney Disease
Current Drug Targets The Role of the Methoxyphenol Apocynin, a Vascular NADPH Oxidase Inhibitor, as a Chemopreventative Agent in the Potential Treatment of Cardiovascular Diseases
Current Vascular Pharmacology The Role of Small, Dense Low-Density-Lipoproteins in Non-Coronary Forms of Atherosclerosis
Vascular Disease Prevention (Discontinued)